Stockreport

Zai Lab to Present Preclinical Data of ZL-1503, an IL-13/IL-31 Bispecific Antibody for the Treatment of Atopic Dermatitis, at EADV Congress 2024 [Yahoo! Finance]

Zai Lab Limited - American Depositary Shares  (ZLAB) 
US:NASDAQ Investor Relations: zailaboratory.com/about/investors.php
PDF ZL-1503 is part of Zai Lab's internally discovered and developed global pipeline SHANGHAI & CAMBRIDGE, Mass., September 17, 2024 BUSINESS WIRE )--Zai Lab Limited (NAS [Read more]